Literature DB >> 8678123

Mutational analysis of the human MAOA gene.

E A Tivol1, C Shalish, D E Schuback, Y P Hsu, X O Breakefield.   

Abstract

The monoamine oxidases (MAO-A and MAO-B) are the enzymes primarily responsible for the degradation of amine neurotransmitters, such as dopamine, norepinephrine, and serotonin. Wide variations in activity of these isozymes have been reported in control humans. The MAOA and MAOB genes are located next to each other in the p11.3-11.4 region of the human X chromosome. Our recent documentation of an MAO-A-deficiency state, apparently associated with impulsive aggressive behavior in males, has focused attention of genetic variations in the MAOA gene. In the present study variations in the coding sequence of the MAOA gene were evaluated by RT-PCR, SSCP, and sequencing a mRNA or genomic DNA in 40 control males with > 100-fold variations of MAO-A activity, as measured in cultured skin fibroblasts. Remarkable conservation of the coding sequence was found with only 5 polymorphisms observed. All but one of these were in the third codon position and thus did not alter the deduced amino acid sequence. The one amino acid alteration observed, lys --> arg, was neutral and should not affect the structure of the protein. This study demonstrates high conservation of coding sequence in the human MAOA gene in control males, and provides primer sets which can be used to search genomic DNA for mutations in this gene in males with neuropsychiatric conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678123     DOI: 10.1002/(SICI)1096-8628(19960216)67:1<92::AID-AJMG16>3.0.CO;2-K

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Evidence for positive selection and population structure at the human MAO-A gene.

Authors:  Yoav Gilad; Shai Rosenberg; Molly Przeworski; Doron Lancet; Karl Skorecki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 2.  The role of non-P450 enzymes in drug oxidation.

Authors:  C Beedham
Journal:  Pharm World Sci       Date:  1997-12

3.  Screen for MAOA mutations in target human groups.

Authors:  D E Schuback; E L Mulligan; K B Sims; E A Tivol; B D Greenberg; S F Chang; S L Yang; Y C Mau; C Y Shen; M S Ho; N H Yang; M G Butler; S Fink; C E Schwartz; F Berlin; X O Breakefield; D L Murphy; Y P Hsu
Journal:  Am J Med Genet       Date:  1999-02-05

Review 4.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

5.  The c.1460C>T polymorphism of MAO-A is associated with the risk of depression in postmenopausal women.

Authors:  R Słopień; A Słopień; A Różycka; A Warenik-Szymankiewicz; M Lianeri; P P Jagodziński
Journal:  ScientificWorldJournal       Date:  2012-04-24

6.  MAOA haplotypes associated with thrombocyte-MAO activity.

Authors:  Mårten Jansson; Shane McCarthy; Patrick F Sullivan; Paul Dickman; Björn Andersson; Lars Oreland; Martin Schalling; Nancy L Pedersen
Journal:  BMC Genet       Date:  2005-09-20       Impact factor: 2.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.